Demographic and clinical characteristics of patients with asthma with/without COVID-19
| Asthma (n=71 182) | Asthma without COVID-19 (n=70 176) | Asthma with COVID-19 (n=1006) | OR (95% CI) p value# | |
| Age | ||||
| Years (mean±sd) | 42±24 | 41±24 | 55±20 | <.001 |
| Sex | ||||
| Female (%) | 59 | 59 | 66 | 1.34 (1.18–1.54) <.001 |
| Tobacco use (%) | 10 | 9 | 11 | 1.25 (1,03–1.53) 0.02 |
| Comorbidities | ||||
| Arterial Hypertension (%) | 24 | 24 | 39 | 2.02 (1.78–2.30) <.001 |
| Dyslipidemia (%) | 17 | 17 | 26 | 1.72 (1.49–1.98) <.001 |
| Diabetes Mellitus (%) | 11 | 10 | 16 | 1.72 (1.45–2.03) <.001 |
| Obesity (%) | 10 | 10 | 13 | 1.35 (1.12–1.62) <.001 |
| Rhinitis (%) | 33 | 33 | 17 | 0.42 (0.35–0.49) <.001 |
| Eczema (%) | 7 | 7 | 1 | 0.50 (0.40–0.76) <.001 |
#Patients with asthma with COVID-19 versus patients with asthma without COVID-19.